Biomarker Discovery in Hepatocellular Carcinoma
碩士 === 國立成功大學 === 分子醫學研究所 === 97 === Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. Most of HCC patients are diagnosed at advanced stage with 5-year survival rate less than 5%. Therefore, an early diagnosis and appropriate treatment planning for HCC...
Main Authors: | Hao-Yi Huang, 黃浩一 |
---|---|
Other Authors: | Nan-Haw Chow |
Format: | Others |
Language: | en_US |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/96210167048460938448 |
Similar Items
-
Discovery of prognostic biomarkers for hepatocellular carcinoma by mass spectrometry-based phosphoproteomics approach
by: Ye Hsuan Sun, et al.
Published: (2018) -
Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
by: Guo W, et al.
Published: (2018-04-01) -
Biomarkers for Hepatocellular Carcinoma
by: Tara Behne, et al.
Published: (2012-01-01) -
Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
by: Qianwei Zhao, et al.
Published: (2020-09-01) -
Discovery of drug resistant genes in hepatocellular carcinoma cells: The functional roles of prothymosin α in chemoresistance of hepatocellular carcinoma
by: Yi Te Lin, et al.
Published: (2015)